Neurocrine biosciences to present at upcoming investor conferences in may

San diego , may 6, 2025 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at two upcoming investor conferences in may. chief executive officer kyle gano and vice-president of investor relations todd tushla will present at the bofa securities 2025 health care conference on tuesday, may 13, 2025 at 11:20 am pacific time in las vegas.
NBIX Ratings Summary
NBIX Quant Ranking